ST Tongde Co., Ltd.

Announcement on Progress Regarding Certain Overdue Company Debts

Announcement on the Progress of Company Litigation Matters

Announcement on participating in the 2026 online collective reception day for investors of listed companies in Shanxi

Announcement on Publicly Soliciting Restructuring Investors

Shanxi Tongde Chemical Co., Ltd. is publicly soliciting restructuring investors through a court-supervised pre-restructuring process. The company seeks investors with strong industrial capabilities to support its transformation, resolve financial risks, and achieve a win-win outcome for all stakeholders. The process involves application, preliminary review, due diligence, and investment proposal submission, with the goal of selecting a qualified investor to facilitate the company's restructuring.

Announcement on Creditor Claims Declaration During Company's Pre-Restructuring Period

This announcement details the pre-restructuring process for Shanxi Tongde Chemical Co., Ltd. The court has accepted the pre-restructuring filing and appointed a preliminary restructuring agent. Creditors are notified to declare their claims by June 15, 2026. Failure to do so may result in the loss of rights. Investors are warned of potential delisting risks.

Announcement on the Progress of Litigation Matters of the Company and its Wholly-Owned Subsidiaries

This announcement details the progress of a lawsuit filed by Evergrowing Bank against the company and its wholly-owned subsidiaries. The first-instance judgment orders the company to repay a principal of RMB 49,000,000 plus interest and legal fees totaling RMB 49,531,656.31. The outcome is not expected to significantly impact current or future profits.

Announcement on Court's Appointment of Pre-Restructuring Assistance Agency

The company announces that the court has appointed its liquidation committee as the pre-restructuring assistance agency. The company's entry into restructuring proceedings remains uncertain. Successful restructuring could improve its financial structure and operations, while failure risks bankruptcy and delisting. Investors are advised to monitor the situation closely.

Audit Report on Special Explanation for Correction of Prior Period Accounting Errors

This report from Lixin Zhonglian CPAs provides an audit opinion on the special explanation prepared by Shanxi Tongde Chemical Co., Ltd. regarding the correction of prior period accounting errors. The errors involved unrecorded gains on employee housing sales and misappropriation of funds. The correction aims to accurately reflect financial performance and position, with adjustments impacting various balance sheet and income statement items across multiple years.

2025 Annual Report of the Board of Directors

The report details the company's 2025 operational performance, highlighting a revenue decrease of 13.25% and a net loss attributable to shareholders. It outlines the board's adherence to regulations, its work in managing risks, and its focus on innovation and steady development. Key financial indicators and business segment performance are presented, along with plans for pre-restructuring and ensuring core business operations in 2026.

2025 Annual Financial Report

This report details the financial status and operating results of Shanxi Tongde Chemical Co., Ltd. for 2025. The company reported total assets of 342,546.63 million yuan, a decrease of 27.33% from the previous year. Total liabilities were 251,725.83 million yuan, a decrease of 7.02%. The company incurred a net loss attributable to shareholders of 109,341.21 million yuan.

Announcement on the Restatement of Financial Statements and Notes After Correction of Prior Accounting Errors

This announcement details the correction of prior accounting errors by Shanxi Tongde Chemical Co., Ltd. The company has restated its financial statements from 2015 to 2024, impacting figures presented in black bold font. This action is in accordance with relevant accounting standards and regulatory requirements to ensure the accuracy and completeness of financial reporting.

Announcement on Correction and Retrospective Adjustment of Prior Period Accounting Errors

Shanxi Tongde Chemical Co., Ltd. announces the correction of prior period accounting errors impacting financial statements from 2015 to 2024. The errors primarily relate to the misstatement of accounts receivable, fixed assets, and other items. The company apologizes for any inconvenience and commits to improving financial reporting quality. The correction does not alter the profit or loss nature of previously disclosed financial statements.

Announcement on Re-appointment of 2026 Audit Firm

The Board of Directors of Shanxi Tongde Chemical Co., Ltd. proposes to re-appoint Lixin Zhonglian Certified Public Accountants (Special General Partnership) as the company's 2026 financial and internal control audit firm. The firm previously issued a qualified opinion for the 2025 audit. The decision requires approval from the 2025 shareholder meeting.

Announcement on the Remuneration Plan for Directors and Senior Management of the Company in 2026

This announcement details the 2026 remuneration plan for directors and senior management of Shanxi Tongde Chemical Co., Ltd. The plan, approved by the board, outlines salary standards based on positions and includes provisions for independent directors' allowances. It also covers payment schedules, expense reimbursements, and adjustments for departures. The plan requires shareholder approval.

2025 Annual Report of Independent Director (Yao Xiaomin)

This report details Yao Xiaomin's performance as an independent director of Shanxi Tongde Chemical Co., Ltd. in 2025. It covers personal qualifications, independence, attendance at board and shareholder meetings, participation in special committees, and communication with internal and external auditors. The director actively fulfilled duties, supervised operations, and protected shareholder interests, particularly those of minority shareholders.

2025 Annual Independent Director Performance Report (Wang Jun, Departed)

This report details the performance of Wang Jun as an independent director for the 2025 fiscal year. It covers his personal background, independence confirmation, attendance at board and shareholder meetings, and participation in special committee work. The report concludes with an overall evaluation of his diligent and responsible fulfillment of duties, emphasizing his contribution to safeguarding shareholder interests.

2025 Independent Director Performance Report (Yang Ruiping, Resigned)

This report details the performance of independent director Yang Ruiping for 2025. It covers her basic information, independence, attendance at board and shareholder meetings, work in special committees, and communication with internal and external auditors. The report concludes that she fulfilled her duties diligently, safeguarding shareholder interests and contributing to corporate governance.

2025 Annual Independent Director's Performance Report (Xue Jianlan)

This report details Xue Jianlan's performance as an independent director for Shanxi Tongde Chemical Co., Ltd. in 2025. She attended all board and shareholder meetings, actively participated in committee work, and maintained communication with management and auditors. Her performance was deemed satisfactory, upholding her duties and protecting shareholder interests.

2025 Annual Independent Director's Performance Report (Zan Zhihong)

This report details the performance of Independent Director Zan Zhihong for 2025. It covers his personal background, independence confirmation, attendance at board and shareholder meetings, participation in special committees, and exercise of director's rights. The director confirms his commitment to safeguarding shareholder interests and contributing to the company's stable operation and performance.

Announcement on Holding the 2025 Annual Performance Briefing

Shanxi Tongde Chemical Co., Ltd. will hold an online performance briefing on May 6, 2026, to discuss its 2025 annual results and development strategies. Investors can submit questions in advance through the "Interactive Yi" platform. Key management personnel will attend to communicate with investors.